Jupiter Neurosciences reported revenue of $0.02M and net income of -$2.27M for the quarter ended Jun 2026. This income statement covers 11 quarters of results from Sep 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | |||||||||||
| Revenue | 0.02M | ||||||||||
| Cost of RevenueCost of Rev | 0.00M | ||||||||||
| Gross Profit | 0.02M | ||||||||||
| Operating items | |||||||||||
| Research & DevelopmentR&D | 0.24M | 0.24M | 0.10M | 0.10M | 0.09M | 0.20M | 0.47M | 0.76M | 0.82M | 0.04M | 0.60M |
| Selling, General & AdministrativeSG&A | 1.20M | 0.29M | 0.47M | 0.46M | 0.40M | 1.26M | 1.07M | 1.51M | 1.48M | 2.78M | 2.16M |
| Operating ExpensesOpex | 1.44M | 0.54M | 0.57M | 0.56M | 0.49M | 1.46M | 1.54M | 2.26M | 2.30M | 2.83M | 2.76M |
| Operating IncomeOp. Inc | -1.44M | -0.54M | -0.57M | -0.56M | -0.49M | -1.46M | -1.54M | -2.26M | -2.30M | -2.81M | -2.74M |
| EBIT | -1.44M | -0.54M | -0.57M | -0.56M | -0.49M | -1.46M | -1.54M | -2.26M | -2.30M | -2.81M | -2.74M |
| Non-operating items | |||||||||||
| Non Operating Interest Expenses | 0.08M | 0.06M | 0.07M | 0.06M | 0.11M | 0.03M | 0.00M | 0.00M | 0.00M | 0.06M | 0.09M |
| Interest & Investment IncomeInt & Inv Inc | 161.00 | -0.04M | 62.00 | 53.00 | 23.00 | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | |
| Other Non Operating IncomeOther Non Op Inc. | -0.22M | -0.04M | 0.01M | -1.01M | 0.55M | ||||||
| Non Operating IncomeNon Op. Inc. | -0.33M | 0.11M | -0.06M | 0.87M | -0.10M | -0.07M | 0.01M | 0.01M | 0.01M | 0.23M | 0.47M |
| Net income details | |||||||||||
| EBT | -1.52M | -0.64M | -0.64M | -0.61M | -0.60M | -1.48M | -1.53M | -2.25M | -2.29M | -2.87M | -2.82M |
| Profit After TaxPAT | -1.77M | -0.43M | -0.63M | 0.31M | -0.59M | -1.53M | -1.53M | -2.25M | -2.29M | -2.58M | -2.27M |
| Income from Continuing OperationsIncome (Continuing) | -1.52M | -0.64M | -0.64M | -0.61M | -0.60M | -1.48M | -1.53M | -2.25M | -2.29M | -2.87M | -2.82M |
| Consolidated Net IncomeConsol Net Inc. | -1.52M | -0.64M | -0.64M | -0.61M | -0.60M | -1.48M | -1.53M | -2.25M | -2.29M | -2.87M | -2.82M |
| Income towards Parent CompanyParent Net Inc | -1.52M | -0.64M | -0.64M | -0.61M | -0.60M | -1.48M | -1.53M | -2.25M | -2.29M | -2.87M | -2.82M |
| Net Income towards Common StockholdersNet Income | -1.52M | -0.64M | -0.64M | -0.61M | -0.60M | -1.48M | -1.53M | -2.25M | -2.29M | -2.87M | -2.82M |
| Additional items | |||||||||||
| EPS (Basic) | -4.33 | -1.81 | -1.80 | -1.67 | -1.45 | -3.87 | -3.46 | -5.09 | -5.04 | -6.22 | -5.06 |
| EPS (Diluted) | -4.33 | -1.81 | -1.80 | -1.50 | -1.45 | -3.87 | -3.46 | -5.09 | -5.04 | -6.22 | -5.06 |
| Shares Outstanding | 0.35M | 0.35M | 0.35M | 0.37M | 0.41M | 0.38M | 0.44M | 0.44M | 0.45M | 0.46M | 0.56M |
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 0.35M | 0.35M | 0.35M | 0.41M | 0.41M | 0.38M | 0.44M | 0.44M | 0.45M | 0.46M | 0.56M |
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 0.35M | 0.35M | 0.35M | 0.40M | 0.40M | 0.44M | 0.44M | 0.46M | 0.46M | 0.46M | 0.66M |
| EBITDA | -1.44M | -0.54M | -0.57M | -0.56M | -0.49M | -1.46M | -1.54M | -2.26M | -2.30M | -2.81M | -2.74M |
| Interest ExpensesInt Expense | 0.08M | 0.06M | 0.07M | 0.06M | 0.11M | 0.03M | 0.00M | 0.00M | 0.00M | 0.06M | 0.09M |